Metraipolis › archive › dc_249fec19f59a

Kefiran as a Novel Biomaterial Ink Component: Preliminary Assessment of 3D Printing Feasibility and Biocompatibility — Europe PMC PMID:42042117

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42042117
DOI
10.3390/gels12040279
License (as archived)
solo-consultazione
Archived
2026-11-03T20:21:47.818Z
SHA-256 of the archived text
68a04d1756631e994637f2236e91ad47640bab8e0612146da81c790ac3e6db5f
Stable URL of this page
https://metraipolis.com/documento/dc_249fec19f59a

How to cite

Kefiran as a Novel Biomaterial Ink Component: Preliminary Assessment of 3D Printing Feasibility and Biocompatibility — Europe PMC PMID:42042117 — Europe PMC (en), https://europepmc.org/article/MED/42042117 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_249fec19f59a (Metraipolis archive dc_249fec19f59a, sha256 68a04d1756631e994637f2236e91ad47640bab8e0612146da81c790ac3e6db5f)
BibTeX
@misc{dc249fec19f59a,
  title = {Kefiran as a Novel Biomaterial Ink Component: Preliminary Assessment of 3D Printing Feasibility and Biocompatibility — Europe PMC PMID:42042117},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42042117},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_249fec19f59a; sha256 68a04d1756631e994637f2236e91ad47640bab8e0612146da81c790ac3e6db5f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42042117. Agents can read the archived copy with the MCP tool read_document.